BioInfra Co., Ltd. (KOSDAQ: 199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,070.00
-420.00 (-6.47%)
Jan 21, 2025, 9:00 AM KST
-47.90%
Market Cap 29.12B
Revenue n/a
Net Income n/a
Shares Out 4.80M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Dec 27, 2024
Volume 58,228
Average Volume 11,017
Open 6,120.00
Previous Close 6,490.00
Day's Range 6,030.00 - 6,200.00
52-Week Range 5,660.00 - 11,900.00
Beta n/a
RSI 37.26
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

News

There is no news available yet.